EPM2AIP1 anticorps (N-Term)
Aperçu rapide pour EPM2AIP1 anticorps (N-Term) (ABIN1881302)
Antigène
Voir toutes EPM2AIP1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 39-62, N-Term
-
Purification
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
Immunogène
- This EPM2AIP1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 39-62 amino acids from the N-terminal region of human EPM2AIP1.
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- WB: 1:1000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Date de péremption
- 6 months
-
-
-
: "Identification of a novel protein interacting with laforin, the EPM2a progressive myoclonus epilepsy gene product." dans: Genomics, Vol. 81, Issue 6, pp. 579-87, (2003) (PubMed).
: "Prediction of the coding sequences of unidentified human genes. XI. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro." dans: DNA research : an international journal for rapid publication of reports on genes and genomes, Vol. 5, Issue 5, pp. 277-86, (1999) (PubMed).
-
-
-